Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
A new study concludes that in-office based imaging facilities fared better than hospital out-patient centers even after three years of steep cuts to in-office care under the Deficit Reduction Act.
The Alberta government in Canadian has called for a sweeping review of all diagnostic imaging and pathology tests in the province after multiple errors were found, which in several cases led to different diagnosis.
For treating patients with peripheral arterial disease (PAD), interventional radiologists cost Medicare less and resulted in better outcomes compared to other specialists.
Vermont radiologists made their opinions known about a proposed 21% cut to Medicaid reimbursement, and the legislature lowered the reduction to just 2%.
GE Healthcare got a little more than it bargained for when it acquired Amersham Health Inc. in 2004. The company recently paid the federal government $30 million to settle allegations that Amersham violated the False Claims Act.
Researchers at Johns Hopkins will begin searching for new ways to detect cancers in the earliest stages within cells using advanced imaging techniques.
Brain imaging techniques could be the most effective way to measure the progression of Huntington Disease, according to a study published this month in The Lancet.